Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,115,800 | 1,323,800 | 654,200 | 461,100 | 2,444,400 |
| Depreciation Amortization | 210,300 | 156,000 | 103,100 | 51,000 | 148,200 |
| Income taxes - deferred | -130,600 | -110,000 | -125,300 | -10,700 | -140,000 |
| Accounts receivable | -523,700 | -464,500 | -247,500 | -91,100 | -236,400 |
| Other Working Capital | -200,500 | -171,200 | 128,900 | 311,500 | -697,000 |
| Other Operating Activity | 958,700 | 908,500 | 571,900 | 175,200 | 675,900 |
| Operating Cash Flow | $2,430,000 | $1,642,600 | $1,085,300 | $897,000 | $2,195,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,598,200 | -1,528,500 | -1,443,200 | -701,800 | -1,069,900 |
| PPE Investments | -429,600 | -290,600 | -168,900 | -74,300 | -383,100 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -10,000 |
| Investing Cash Flow | $-2,027,800 | $-1,819,100 | $-1,612,100 | $-776,100 | $-1,463,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 211,800 | 163,500 | 155,100 | 140,600 | 114,500 |
| Common Stock Repurchased | -463,900 | -69,900 | -50,500 | -20,700 | -191,600 |
| Financing Cash Flow | $-252,100 | $93,600 | $104,600 | $119,900 | $-77,100 |
| Beginning Cash Position | 1,480,200 | 1,480,200 | 1,480,200 | 1,480,200 | 825,200 |
| End Cash Position | 1,630,300 | 1,397,300 | 1,058,000 | 1,721,000 | 1,480,200 |
| Net Cash Flow | $150,100 | $-82,900 | $-422,200 | $240,800 | $655,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,430,000 | 1,642,600 | 1,085,300 | 897,000 | 2,195,100 |
| Capital Expenditure | -429,600 | -290,600 | -168,900 | -74,300 | -383,100 |
| Free Cash Flow | 2,000,400 | 1,352,000 | 916,400 | 822,700 | 1,812,000 |